CD160

Protein found in humans From Wikipedia, the free encyclopedia

CD160 antigen is a protein that in humans is encoded by the CD160 gene.[5][6][7]

AliasesCD160, BY55, NK1, NK28, CD160 molecule
End145,739,288 bp[1]
Quick facts Identifiers, Aliases ...
CD160
Identifiers
AliasesCD160, BY55, NK1, NK28, CD160 molecule
External IDsOMIM: 604463; MGI: 1860383; HomoloGene: 5122; GeneCards: CD160; OMA:CD160 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_007053

NM_001163496
NM_001163497
NM_018767

RefSeq (protein)

NP_008984

NP_001156968
NP_001156969
NP_061237

Location (UCSC)Chr 1: 145.72 – 145.74 MbChr 3: 96.71 – 96.74 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
Close

CD160 is a 27 kDa glycoprotein which was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine-rich, glycosylphosphatidylinositol-anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule. CD160 is expressed at the cell surface as a tightly disulfide-linked multimer. RNA blot analysis revealed CD160 mRNAs of 1.5 and 1.6 kb whose expression was highly restricted to circulating NK and T cells, spleen and small intestine. Within NK cells CD160 is expressed by CD56dimCD16+ cells whereas among circulating T cells its expression is mainly restricted to TCRgd bearing cells and to TCRab+CD8brightCD95+CD56+CD28-CD27-cells. In tissues, CD160 is expressed on all intestinal intraepithelial lymphocytes. CD160 shows a broad specificity for binding to both classical and nonclassical MHC class I molecules.[7]

Clinical significance

CD160 is a ligand for HVEM, and considered a proposed immune checkpoint inhibitor with anti-cancer activity along with anti- PD-1 antibodies.[8] CD160 has also been proposed as a potential new target in cases of human pathological ocular and tumor neoangiogenesis that do not respond or become resistant to existing antiangiogenic drugs.[9]

See also

References

Further reading

Related Articles

Wikiwand AI